Tseng JH - Search Results

1

Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.

Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine DA, Abu-Rustum NR, Tew WP, Chi DS, Long Roche K. Tseng JH, et al. Gynecol Oncol. 2016 Aug;142(2):217-24. doi: 10.1016/j.ygyno.2016.05.035. Epub 2016 Jun 4. Gynecol Oncol. 2016. PMID: 27261325 Free PMC article.

2

High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes.

Doll KM, Tseng J, Denslow SA, Fader AN, Gehrig PA. Doll KM, et al. Gynecol Oncol. 2014 Jan;132(1):44-9. doi: 10.1016/j.ygyno.2013.10.023. Epub 2013 Oct 29. Gynecol Oncol. 2014. PMID: 24183734

3

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent ovarian carcinoma: analysis of 30-day morbidity and mortality.

Cripe J, Tseng J, Eskander R, Fader AN, Tanner E, Bristow R. Cripe J, et al. Ann Surg Oncol. 2015 Feb;22(2):655-61. doi: 10.1245/s10434-014-4026-6. Epub 2014 Aug 26. Ann Surg Oncol. 2015. PMID: 25155402

4

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.

Jelinic P, Schlappe BA, Conlon N, Tseng J, Olvera N, Dao F, Mueller JJ, Hussein Y, Soslow RA, Levine DA. Jelinic P, et al. Mod Pathol. 2016 Jan;29(1):60-6. doi: 10.1038/modpathol.2015.129. Epub 2015 Nov 13. Mod Pathol. 2016. PMID: 26564006 Free PMC article.

5

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.

Dao F, Schlappe BA, Tseng J, Lester J, Nick AM, Lutgendorf SK, McMeekin S, Coleman RL, Moore KN, Karlan BY, Sood AK, Levine DA. Dao F, et al. Gynecol Oncol. 2016 May;141(2):260-263. doi: 10.1016/j.ygyno.2016.03.010. Epub 2016 Mar 11. Gynecol Oncol. 2016. PMID: 26968641 Free PMC article.

6

The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.

Jelinic P, Eccles LA, Tseng J, Cybulska P, Wielgos M, Powell SN, Levine DA. Jelinic P, et al. Oncotarget. 2017 Feb 21;8(8):13792-13804. doi: 10.18632/oncotarget.14637. Oncotarget. 2017. PMID: 28099152 Free PMC article.

7

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.

Tseng JH, Bisogna M, Hoang LN, Olvera N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Levine DA, Jelinic P. Tseng JH, et al. Sci Rep. 2017 Jun 15;7(1):3614. doi: 10.1038/s41598-017-03972-7. Sci Rep. 2017. PMID: 28620240 Free PMC article.

8

Compliance with research standards within gynecologic oncology fellowship: A Gynecologic Oncology Fellowship Research Network (GOFRN) study.

Moulton LJ, Michener CM, Levinson K, Cobb L, Tseng J, Jernigan A. Moulton LJ, et al. Gynecol Oncol. 2017 Sep;146(3):647-652. doi: 10.1016/j.ygyno.2017.06.034. Epub 2017 Jul 8. Gynecol Oncol. 2017. PMID: 28698010

9

Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.

Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, Gardner GJ, Chi DS, Park BJ, Sonoda Y. Cowan RA, et al. Gynecol Oncol. 2017 Nov;147(2):262-266. doi: 10.1016/j.ygyno.2017.09.001. Epub 2017 Sep 6. Gynecol Oncol. 2017. PMID: 28888540 Free PMC article.

10

Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center.

Cowan RA, Tseng J, Ali N, Dearie H, Murthy V, Gennarelli RL, Iasonos A, Abu-Rustum NR, Chi DS, Long Roche KC, Brown CL. Cowan RA, et al. Gynecol Oncol. 2018 Apr;149(1):43-48. doi: 10.1016/j.ygyno.2017.11.012. Gynecol Oncol. 2018. PMID: 29605049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters